In a new Everyday Health article by Korin Miller, I joined Lisa Moskovitz, RD, CEO of NY Nutrition Group, and Scott Keatley, RD, co-owner of Keatley Medical Nutrition Therapy, to examine the diets claims, potential benefits, and some significant red flags
Mounjaro and Zepbound have positioned Lilly as a commercial force, while retatrutide and orforglipron give the company strong next-generation optionality
The findings were made by researchers at the University of Colorado Anschutz Medical Campus, who observed unusual changes in brain connectivity while studying adolescents and young women taking GLP-1 medications for a hormonal condition affecting the ovaries, The Washington Post reported
Remember that experiencing side effects does not mean the medication is not working for you